Published in West J Med on September 01, 1985
Structure of the porcine LH- and FSH-releasing hormone. I. The proposed amino acid sequence. Biochem Biophys Res Commun (1971) 2.67
New approach in the treatment of prostate cancer: complete instead of partial withdrawal of androgens. Prostate (1983) 2.29
Influence of disodium etidronate on clinical and laboratory manifestations of Paget's disease of bone (osteitis deformans). N Engl J Med (1973) 1.41
Cancer statistics, 1984. CA Cancer J Clin (1984) 1.20
Ketoconazole therapy in advanced prostatic cancer. J Urol (1984) 1.17
Prostate tumor biology and cell kinetics--theory. Urology (1981) 1.05
The national survey of prostate cancer in the United States by the American College of Surgeons. J Urol (1982) 1.04
Treatment of newly diagnosed metastatic prostate cancer patients with chemotherapy agents in combination with hormones versus hormones alone. Cancer (1983) 1.04
Experience with flutamide in previously untreated patients with advanced prostatic cancer. J Urol (1979) 0.87
Edward T. Tyler Prize Oration: LH-releasing hormone and its analogues: recent basic and clinical investigations. Int J Fertil (1976) 0.84
Management of newly diagnosed metastatic carcinoma of the prostate. Urol Clin North Am (1984) 0.84
Early combined hormonal and chemotherapy for metastatic prostatic carcinoma. Urology (1983) 0.81
Pediatric Vesicoureteral Reflux Guidelines Panel summary report on the management of primary vesicoureteral reflux in children. J Urol (1997) 2.32
Xanthogranulomatous pyelonephritis: a critical analysis of 26 cases and of the literature. J Urol (1978) 2.20
Latent carcinoma of the prostate--why the controversy? J Urol (1974) 1.48
Prostate Cancer Clinical Guidelines Panel Summary report on the management of clinically localized prostate cancer. The American Urological Association. J Urol (1995) 1.47
Synthesis and antibacterial properties of beta-diketone acrylate bioisosteres of pseudomonic acid A. Bioorg Med Chem Lett (1999) 1.45
Bladder prolapse in a female infant with complete epispadias. J Urol (1997) 1.40
Infected urachal cysts: a review of 10 cases. J Urol (1988) 1.39
Is deleting the digital rectal examination a good idea? West J Med (1991) 1.38
Segmental multicystic kidney and ipsilateral duplication anomalies. J Urol (1996) 1.38
Congenital anterior urethrocutaneous fistula. J Urol (1999) 1.35
Experience with triple-drug therapy in a pharmacological erection program. J Urol (1993) 1.09
Are pediatric patients more susceptible to major renal injury from blunt trauma? A comparative study. J Urol (1998) 1.08
Onlay island flap in the repair of mid and distal penile hypospadias without chordee. J Urol (1987) 1.08
Suprainguinal ectopic scrotum and associated anomalies. J Urol (1982) 1.05
Treatment of newly diagnosed metastatic prostate cancer patients with chemotherapy agents in combination with hormones versus hormones alone. Cancer (1983) 1.04
Immunochemical detection of serum prostatic acid phosphatase. Methodology and clinical evaluation. Invest Urol (1978) 1.03
Gracilis muscle flap for closure of rectourethral fistula. J Urol (1979) 1.03
Needle tract seeding following aspiration of renal cell carcinoma. J Urol (1977) 0.99
Total prostatectomy for localized prostatic cancer. J Urol (1984) 0.98
Androgenic sensitivity of the gubernaculum testis: evidence for hormonal/mechanical interactions in testicular descent. J Urol (1982) 0.97
Kidney stone removal: percutaneous versus surgical lithotomy. J Urol (1985) 0.97
Major blunt renal trauma in the pediatric population: is a nonoperative approach indicated? J Urol (1993) 0.97
Cystic pheochromocytoma. Urology (1985) 0.95
Use of ureteral stents in the management of major renal trauma with urinary extravasation: is there a role? J Endourol (1998) 0.94
Experience with indwelling ureteral stent catheters. J Urol (1976) 0.93
Calcified vesical foreign body. Am J Dis Child (1986) 0.93
Radical perineal prostatectomy for clinical stage B2 carcinoma of the prostate. J Urol (1982) 0.93
Needle tract seeding of renal cell carcinoma. AJR Am J Roentgenol (1977) 0.91
Urethral prolapse: an often misdiagnosed cause of urogenital bleeding in girls. Pediatr Emerg Care (1995) 0.90
Reno-colic and reno-colic-cutaneous fistula: report of 3 cases. J Urol (1965) 0.90
Primary adenocarcinoma of bladder. Urology (1980) 0.90
Extracorporeal shock-wave lithotripsy for bile duct calculi. Am J Surg (1998) 0.89
Shortcomings of color Doppler sonography in the diagnosis of testicular torsion. J Urol (1995) 0.89
Pubovaginal slings using fascia lata for the treatment of intrinsic sphincter deficiency. J Urol (1997) 0.89
Chemotherapy of advanced prostatic cancer by the National Prostatic Cancer Group. Semin Oncol (1976) 0.88
Manifestations of renal cell carcinoma. Urology (1976) 0.88
Hyperbaric oxygen therapy for radiation-induced hemorrhagic cystitis. J Urol (1993) 0.88
Adjuvant radiotherapy following radical prostatectomy: results and complications. J Urol (1986) 0.88
Cryptorchidism: isolated and associated with other genitourinary defects. Pediatr Clin North Am (1987) 0.87
The accuracy of antenatal ultrasonography in identifying renal abnormalities. Am J Dis Child (1992) 0.87
Radiologic evaluation of pediatric blunt renal trauma in patients with microscopic hematuria. World J Surg (2001) 0.86
Double antimicrobial prophylaxis in girls with breakthrough urinary tract infections. Urology (1994) 0.86
Management of newly diagnosed metastatic carcinoma of the prostate. Urol Clin North Am (1984) 0.84
Mechanical reliability, surgical complications, and patient and partner satisfaction of the modern three-piece inflatable penile prosthesis. Urology (1998) 0.83
A comparison of hydroxyurea, methyl-chloroethyl-cyclohexy-nitrosourea and cyclophosphamide in patients with advanced carcinoma of the prostate. J Urol (1981) 0.83
Prostate cancer. Chemotherapy. Cancer (1987) 0.83
Microvascular management of multiple renal arteries in transplantation. J Urol (1982) 0.83
Urologic consequences of myelodysplasia and other congenital abnormalities of the spinal cord. Urol Clin North Am (1993) 0.82
Chemotherapy of advanced prostatic cancer. Evaluation of response parameters. Urology (1976) 0.82
Comparison of effects of suture materials on wound healing in a rabbit pyeloplasty model. Urology (1997) 0.82
Radiation exposure to patient and urologist during percutaneous nephrostolithotomy. J Urol (1984) 0.82
The continued evaluation of the effects of chemotherapy in patients with advanced carcinoma of the prostate. J Urol (1976) 0.82
Adjuvant therapy for localized prostate cancer. Cancer (1993) 0.81
Total prostatectomy for stage B carcinoma of the prostate. J Urol (1977) 0.81
Preputial calculus: a case report. J Urol (1986) 0.81
Posterior urethral obliteration treated by endoscopic reconstitution, internal urethrotomy and temporary self-dilation. J Urol (1993) 0.81
Adjuvant therapy for clinical localized prostate cancer treated with surgery or irradiation. Eur Urol (1996) 0.80
Contralateral vesicoureteral reflux in children with a multicystic kidney. J Urol (1995) 0.80
Experience with indwelling silicone rubber ureteral catheters. J Urol (1974) 0.79
Carcinoma of the prostate: local control with external beam radiation therapy. J Urol (1979) 0.79
The chemistry of pseudomonic acid. 17. Dual-action C-1 oxazole derivatives of pseudomonic acid having an extended spectrum of antibacterial activity. J Med Chem (1996) 0.79
Neonatal testis tumors: a review of the Prepubertal Testis Tumor Registry. J Urol (1994) 0.79
Clinical significance of serum alkaline phosphatase isoenzyme levels in advanced prostatic carcinoma. J Urol (1978) 0.78
Chemotherapy of advanced prostatic carcinoma with cyclophosphamide or 5-fluorouracil: results of first national randomized study. J Urol (1975) 0.78
Surgical management of renal lesions using in situ hypothermia and ischemia. J Urol (1976) 0.78
Comparison of estramustine phosphate, methotrexate and cis-platinum in patients with advanced, hormone refractory prostate cancer. J Urol (1983) 0.78
Levels of urinary inter-alpha-trypsin inhibitor trimer as a function of age and sex-hormone status in males and females not forming stones. BJU Int (2002) 0.78
Prognosis in stage D-1 prostate cancer relative to anatomic sites of nodal metastases. National Prostatic Cancer Treatment Group. Cancer (1989) 0.78
Influence of vas deferens mobilization on rat fertility: implications regarding orchiopexy. J Urol (1993) 0.77
Granulomatous prostatitis: confusion clinically with carcinoma of the prostate. J Urol (1977) 0.77
Structure-activity relationships of some arylglycine analogues and catechol isosteres of BRL 36650, a 6 alpha-formamido penicillin. J Antibiot (Tokyo) (1990) 0.77
Renal pelvic tumors. J Urol (1975) 0.77
Morbidity of radical perineal prostatectomy following transurethral resection of the prostate. J Urol (1984) 0.77
Quality control of radiation therapy in multi-institutional randomized clinical trial for localized prostate cancer. Urology (1988) 0.77
Gibbons ureteral stents. Urol Clin North Am (1982) 0.77
The prophylactic use--or misuse--of antibiotics in transurethral prostatectomy. J Urol (1978) 0.76
Cyst of the ejaculatory duct/urogenital sinus. J Urol (1984) 0.76
The continued evaluation of the effects of chemotherapy in patients with advanced carcinoma of the prostate. Trans Am Assoc Genitourin Surg (1976) 0.76
The use of estramustine and prednimustine versus prednimustine alone in advanced metastatic prostatic cancer patients who have received prior irradiation. Trans Am Assoc Genitourin Surg (1978) 0.76
A comparison of estramustine phosphate and streptozotocin in patients with advanced prostatic carcinoma who have had extensive irradiation. J Urol (1977) 0.76
Extracorporeal shock wave lithotripsy for obstructing pancreatic duct calculi. J Urol (1997) 0.76
Comparison of procarbazine, imidazole-carboxamide and cyclophosphamide in relapsing patients with advanced carcinoma of the prostate. J Urol (1979) 0.76
Segmental resection in the management of bladder carcinoma. J Urol (1978) 0.75
Urology: treatment of cancer of the prostate. West J Med (1985) 0.75
Prostate specific antigen detected prostate cancer. J Urol (1996) 0.75
Clinical significance of serum acid phosphatase levels in advanced prostatic carcinoma. Urology (1976) 0.75
Re: The contemporary incidence of lymph node metastases in prostate cancer: implications for laparoscopic lymph node dissection. J Urol (1994) 0.75
Re: Cancer control following anatomical radical prostatectomy: an interim report. J Urol (1992) 0.75
The use of adrenalectomy as a treatment for congenital adrenal hyperplasia. J Urol (1997) 0.75
Bladder rehabilitation, the effect of a cognitive training programme on urge incontinence. J Urol (1997) 0.75
Prenatal predisposition and the clinical management of some pediatric conditions. J Urol (1997) 0.75
The cecostomy button. J Urol (1998) 0.75
Editorial: to be male or female--that is the question. J Urol (1997) 0.75
Measurements of serum Müllerian inhibiting substance in the evaluation of children with nonpalpable gonads. J Urol (1997) 0.75